Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies Article Swipe
Lúcio Ricardo Leite Diniz
,
Yunierkis Pérez‐Castillo
,
Hatem A. Elshabrawy
,
Carlos da Silva Maia Bezerra Filho
,
Damião Pergentino de Sousa
·
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.3390/biom11010074
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.3390/biom11010074
The coronavirus disease 2019 (COVID-19) pandemic is caused by a novel coronavirus; the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Millions of cases and deaths to date have resulted in a global challenge for healthcare systems. COVID-19 has a high mortality rate, especially in elderly individuals with pre-existing chronic comorbidities. There are currently no effective therapeutic approaches for the prevention and treatment of COVID-19. Therefore, the identification of effective therapeutics is a necessity. Terpenes are the largest class of natural products that could serve as a source of new drugs or as prototypes for the development of effective pharmacotherapeutic agents. In the present study, we discuss the antiviral activity of these natural products and we perform simulations against the Mpro and PLpro enzymes of SARS-CoV-2. Our results strongly suggest the potential of these compounds against human coronaviruses, including SARS-CoV-2.
Related Topics
Concepts
Pandemic
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Coronavirus
Proteases
Terpene
2019-20 coronavirus outbreak
Medicine
Pharmacology
Biology
Disease
Computational biology
Virology
Enzyme
Infectious disease (medical specialty)
Biochemistry
Internal medicine
Outbreak
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3390/biom11010074
- https://www.mdpi.com/2218-273X/11/1/74/pdf?version=1610108687
- OA Status
- gold
- Cited By
- 56
- References
- 71
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3121112951
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3121112951Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3390/biom11010074Digital Object Identifier
- Title
-
Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling StudiesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-01-07Full publication date if available
- Authors
-
Lúcio Ricardo Leite Diniz, Yunierkis Pérez‐Castillo, Hatem A. Elshabrawy, Carlos da Silva Maia Bezerra Filho, Damião Pergentino de SousaList of authors in order
- Landing page
-
https://doi.org/10.3390/biom11010074Publisher landing page
- PDF URL
-
https://www.mdpi.com/2218-273X/11/1/74/pdf?version=1610108687Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.mdpi.com/2218-273X/11/1/74/pdf?version=1610108687Direct OA link when available
- Concepts
-
Pandemic, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus, Proteases, Terpene, 2019-20 coronavirus outbreak, Medicine, Pharmacology, Biology, Disease, Computational biology, Virology, Enzyme, Infectious disease (medical specialty), Biochemistry, Internal medicine, OutbreakTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
56Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 7, 2024: 6, 2023: 8, 2022: 20, 2021: 15Per-year citation counts (last 5 years)
- References (count)
-
71Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3121112951 |
|---|---|
| doi | https://doi.org/10.3390/biom11010074 |
| ids.doi | https://doi.org/10.3390/biom11010074 |
| ids.mag | 3121112951 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/33430299 |
| ids.openalex | https://openalex.org/W3121112951 |
| fwci | 4.77908894 |
| mesh[0].qualifier_ui | Q000737 |
| mesh[0].descriptor_ui | D000998 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | chemistry |
| mesh[0].descriptor_name | Antiviral Agents |
| mesh[1].qualifier_ui | Q000494 |
| mesh[1].descriptor_ui | D000998 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | pharmacology |
| mesh[1].descriptor_name | Antiviral Agents |
| mesh[2].qualifier_ui | Q000821 |
| mesh[2].descriptor_ui | D000086382 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | virology |
| mesh[2].descriptor_name | COVID-19 |
| mesh[3].qualifier_ui | Q000037 |
| mesh[3].descriptor_ui | D000086782 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | antagonists & inhibitors |
| mesh[3].descriptor_name | Coronavirus 3C Proteases |
| mesh[4].qualifier_ui | Q000378 |
| mesh[4].descriptor_ui | D000086782 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | metabolism |
| mesh[4].descriptor_name | Coronavirus 3C Proteases |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D055808 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Drug Discovery |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D006801 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Humans |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D062105 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Molecular Docking Simulation |
| mesh[8].qualifier_ui | Q000737 |
| mesh[8].descriptor_ui | D011480 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | chemistry |
| mesh[8].descriptor_name | Protease Inhibitors |
| mesh[9].qualifier_ui | Q000494 |
| mesh[9].descriptor_ui | D011480 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | pharmacology |
| mesh[9].descriptor_name | Protease Inhibitors |
| mesh[10].qualifier_ui | Q000187 |
| mesh[10].descriptor_ui | D000086402 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | drug effects |
| mesh[10].descriptor_name | SARS-CoV-2 |
| mesh[11].qualifier_ui | Q000201 |
| mesh[11].descriptor_ui | D000086402 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | enzymology |
| mesh[11].descriptor_name | SARS-CoV-2 |
| mesh[12].qualifier_ui | Q000737 |
| mesh[12].descriptor_ui | D013729 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | chemistry |
| mesh[12].descriptor_name | Terpenes |
| mesh[13].qualifier_ui | Q000494 |
| mesh[13].descriptor_ui | D013729 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | pharmacology |
| mesh[13].descriptor_name | Terpenes |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D000093485 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | COVID-19 Drug Treatment |
| mesh[15].qualifier_ui | Q000737 |
| mesh[15].descriptor_ui | D000998 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | chemistry |
| mesh[15].descriptor_name | Antiviral Agents |
| mesh[16].qualifier_ui | Q000494 |
| mesh[16].descriptor_ui | D000998 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | pharmacology |
| mesh[16].descriptor_name | Antiviral Agents |
| mesh[17].qualifier_ui | Q000821 |
| mesh[17].descriptor_ui | D000086382 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | virology |
| mesh[17].descriptor_name | COVID-19 |
| mesh[18].qualifier_ui | Q000037 |
| mesh[18].descriptor_ui | D000086782 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | antagonists & inhibitors |
| mesh[18].descriptor_name | Coronavirus 3C Proteases |
| mesh[19].qualifier_ui | Q000378 |
| mesh[19].descriptor_ui | D000086782 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | metabolism |
| mesh[19].descriptor_name | Coronavirus 3C Proteases |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D055808 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Drug Discovery |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D006801 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Humans |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D062105 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Molecular Docking Simulation |
| mesh[23].qualifier_ui | Q000737 |
| mesh[23].descriptor_ui | D011480 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | chemistry |
| mesh[23].descriptor_name | Protease Inhibitors |
| mesh[24].qualifier_ui | Q000494 |
| mesh[24].descriptor_ui | D011480 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | pharmacology |
| mesh[24].descriptor_name | Protease Inhibitors |
| mesh[25].qualifier_ui | Q000187 |
| mesh[25].descriptor_ui | D000086402 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | drug effects |
| mesh[25].descriptor_name | SARS-CoV-2 |
| mesh[26].qualifier_ui | Q000201 |
| mesh[26].descriptor_ui | D000086402 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | enzymology |
| mesh[26].descriptor_name | SARS-CoV-2 |
| mesh[27].qualifier_ui | Q000737 |
| mesh[27].descriptor_ui | D013729 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | chemistry |
| mesh[27].descriptor_name | Terpenes |
| mesh[28].qualifier_ui | Q000494 |
| mesh[28].descriptor_ui | D013729 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | pharmacology |
| mesh[28].descriptor_name | Terpenes |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D000093485 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | COVID-19 Drug Treatment |
| type | article |
| title | Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies |
| biblio.issue | 1 |
| biblio.volume | 11 |
| biblio.last_page | 74 |
| biblio.first_page | 74 |
| topics[0].id | https://openalex.org/T11882 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9993000030517578 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Plant biochemistry and biosynthesis |
| topics[1].id | https://openalex.org/T10225 |
| topics[1].field.id | https://openalex.org/fields/11 |
| topics[1].field.display_name | Agricultural and Biological Sciences |
| topics[1].score | 0.9976999759674072 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1106 |
| topics[1].subfield.display_name | Food Science |
| topics[1].display_name | Essential Oils and Antimicrobial Activity |
| topics[2].id | https://openalex.org/T10211 |
| topics[2].field.id | https://openalex.org/fields/17 |
| topics[2].field.display_name | Computer Science |
| topics[2].score | 0.9975000023841858 |
| topics[2].domain.id | https://openalex.org/domains/3 |
| topics[2].domain.display_name | Physical Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1703 |
| topics[2].subfield.display_name | Computational Theory and Mathematics |
| topics[2].display_name | Computational Drug Discovery Methods |
| is_xpac | False |
| apc_list.value | 2100 |
| apc_list.currency | CHF |
| apc_list.value_usd | 2273 |
| apc_paid.value | 2100 |
| apc_paid.currency | CHF |
| apc_paid.value_usd | 2273 |
| concepts[0].id | https://openalex.org/C89623803 |
| concepts[0].level | 5 |
| concepts[0].score | 0.7356907725334167 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q12184 |
| concepts[0].display_name | Pandemic |
| concepts[1].id | https://openalex.org/C3008058167 |
| concepts[1].level | 4 |
| concepts[1].score | 0.70770263671875 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[1].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[2].id | https://openalex.org/C3007834351 |
| concepts[2].level | 5 |
| concepts[2].score | 0.6356741786003113 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q82069695 |
| concepts[2].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| concepts[3].id | https://openalex.org/C2777648638 |
| concepts[3].level | 5 |
| concepts[3].score | 0.6101683378219604 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q57751738 |
| concepts[3].display_name | Coronavirus |
| concepts[4].id | https://openalex.org/C182220744 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5868722796440125 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7251226 |
| concepts[4].display_name | Proteases |
| concepts[5].id | https://openalex.org/C44937612 |
| concepts[5].level | 2 |
| concepts[5].score | 0.47849076986312866 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q212364 |
| concepts[5].display_name | Terpene |
| concepts[6].id | https://openalex.org/C3006700255 |
| concepts[6].level | 3 |
| concepts[6].score | 0.4549424946308136 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q81068910 |
| concepts[6].display_name | 2019-20 coronavirus outbreak |
| concepts[7].id | https://openalex.org/C71924100 |
| concepts[7].level | 0 |
| concepts[7].score | 0.38837313652038574 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[7].display_name | Medicine |
| concepts[8].id | https://openalex.org/C98274493 |
| concepts[8].level | 1 |
| concepts[8].score | 0.3867822289466858 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[8].display_name | Pharmacology |
| concepts[9].id | https://openalex.org/C86803240 |
| concepts[9].level | 0 |
| concepts[9].score | 0.3555508852005005 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[9].display_name | Biology |
| concepts[10].id | https://openalex.org/C2779134260 |
| concepts[10].level | 2 |
| concepts[10].score | 0.34658539295196533 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[10].display_name | Disease |
| concepts[11].id | https://openalex.org/C70721500 |
| concepts[11].level | 1 |
| concepts[11].score | 0.3280251622200012 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[11].display_name | Computational biology |
| concepts[12].id | https://openalex.org/C159047783 |
| concepts[12].level | 1 |
| concepts[12].score | 0.2893405258655548 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[12].display_name | Virology |
| concepts[13].id | https://openalex.org/C181199279 |
| concepts[13].level | 2 |
| concepts[13].score | 0.26038891077041626 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q8047 |
| concepts[13].display_name | Enzyme |
| concepts[14].id | https://openalex.org/C524204448 |
| concepts[14].level | 3 |
| concepts[14].score | 0.2046554684638977 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[14].display_name | Infectious disease (medical specialty) |
| concepts[15].id | https://openalex.org/C55493867 |
| concepts[15].level | 1 |
| concepts[15].score | 0.09183713793754578 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[15].display_name | Biochemistry |
| concepts[16].id | https://openalex.org/C126322002 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0746178925037384 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[16].display_name | Internal medicine |
| concepts[17].id | https://openalex.org/C116675565 |
| concepts[17].level | 2 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q3241045 |
| concepts[17].display_name | Outbreak |
| keywords[0].id | https://openalex.org/keywords/pandemic |
| keywords[0].score | 0.7356907725334167 |
| keywords[0].display_name | Pandemic |
| keywords[1].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[1].score | 0.70770263671875 |
| keywords[1].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[2].id | https://openalex.org/keywords/severe-acute-respiratory-syndrome-coronavirus-2 |
| keywords[2].score | 0.6356741786003113 |
| keywords[2].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| keywords[3].id | https://openalex.org/keywords/coronavirus |
| keywords[3].score | 0.6101683378219604 |
| keywords[3].display_name | Coronavirus |
| keywords[4].id | https://openalex.org/keywords/proteases |
| keywords[4].score | 0.5868722796440125 |
| keywords[4].display_name | Proteases |
| keywords[5].id | https://openalex.org/keywords/terpene |
| keywords[5].score | 0.47849076986312866 |
| keywords[5].display_name | Terpene |
| keywords[6].id | https://openalex.org/keywords/2019-20-coronavirus-outbreak |
| keywords[6].score | 0.4549424946308136 |
| keywords[6].display_name | 2019-20 coronavirus outbreak |
| keywords[7].id | https://openalex.org/keywords/medicine |
| keywords[7].score | 0.38837313652038574 |
| keywords[7].display_name | Medicine |
| keywords[8].id | https://openalex.org/keywords/pharmacology |
| keywords[8].score | 0.3867822289466858 |
| keywords[8].display_name | Pharmacology |
| keywords[9].id | https://openalex.org/keywords/biology |
| keywords[9].score | 0.3555508852005005 |
| keywords[9].display_name | Biology |
| keywords[10].id | https://openalex.org/keywords/disease |
| keywords[10].score | 0.34658539295196533 |
| keywords[10].display_name | Disease |
| keywords[11].id | https://openalex.org/keywords/computational-biology |
| keywords[11].score | 0.3280251622200012 |
| keywords[11].display_name | Computational biology |
| keywords[12].id | https://openalex.org/keywords/virology |
| keywords[12].score | 0.2893405258655548 |
| keywords[12].display_name | Virology |
| keywords[13].id | https://openalex.org/keywords/enzyme |
| keywords[13].score | 0.26038891077041626 |
| keywords[13].display_name | Enzyme |
| keywords[14].id | https://openalex.org/keywords/infectious-disease |
| keywords[14].score | 0.2046554684638977 |
| keywords[14].display_name | Infectious disease (medical specialty) |
| keywords[15].id | https://openalex.org/keywords/biochemistry |
| keywords[15].score | 0.09183713793754578 |
| keywords[15].display_name | Biochemistry |
| keywords[16].id | https://openalex.org/keywords/internal-medicine |
| keywords[16].score | 0.0746178925037384 |
| keywords[16].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.3390/biom11010074 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210236520 |
| locations[0].source.issn | 2218-273X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2218-273X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Biomolecules |
| locations[0].source.host_organization | https://openalex.org/P4310310987 |
| locations[0].source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310310987 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.mdpi.com/2218-273X/11/1/74/pdf?version=1610108687 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Biomolecules |
| locations[0].landing_page_url | https://doi.org/10.3390/biom11010074 |
| locations[1].id | pmid:33430299 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Biomolecules |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/33430299 |
| locations[2].id | pmh:oai:doaj.org/article:8a8e738125a34b96b4d15b675ecf3514 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | cc-by-sa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Biomolecules, Vol 11, Iss 1, p 74 (2021) |
| locations[2].landing_page_url | https://doaj.org/article/8a8e738125a34b96b4d15b675ecf3514 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:7825698 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Biomolecules |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7825698 |
| locations[4].id | pmh:oai:europepmc.org:6732459 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S4306400806 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | Europe PMC (PubMed Central) |
| locations[4].source.host_organization | https://openalex.org/I1303153112 |
| locations[4].source.host_organization_name | European Bioinformatics Institute |
| locations[4].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[4].license | other-oa |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | Text |
| locations[4].license_id | https://openalex.org/licenses/other-oa |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | |
| locations[4].landing_page_url | http://europepmc.org/pmc/articles/PMC7825698 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5028147816 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-8260-2002 |
| authorships[0].author.display_name | Lúcio Ricardo Leite Diniz |
| authorships[0].affiliations[0].raw_affiliation_string | College of Nordeste da Bahia, Coronel João Sá 48590-000, Brazil |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Lúcio Ricardo Leite Diniz |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | College of Nordeste da Bahia, Coronel João Sá 48590-000, Brazil |
| authorships[1].author.id | https://openalex.org/A5040406602 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-3710-0035 |
| authorships[1].author.display_name | Yunierkis Pérez‐Castillo |
| authorships[1].countries | EC |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210102282 |
| authorships[1].affiliations[0].raw_affiliation_string | Bio-Cheminformatics Research Group and Escuela de Ciencias Físicas y Matemáticas, Universidad de Las Américas, Quito 170125, Ecuador |
| authorships[1].institutions[0].id | https://openalex.org/I4210102282 |
| authorships[1].institutions[0].ror | https://ror.org/0198j4566 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210102282 |
| authorships[1].institutions[0].country_code | EC |
| authorships[1].institutions[0].display_name | Universidad de Las Américas |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Yunierkis Perez-Castillo |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Bio-Cheminformatics Research Group and Escuela de Ciencias Físicas y Matemáticas, Universidad de Las Américas, Quito 170125, Ecuador |
| authorships[2].author.id | https://openalex.org/A5070953775 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-7771-113X |
| authorships[2].author.display_name | Hatem A. Elshabrawy |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I191429286 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Molecular and Cellular Biology, College of Osteopathic Medicine, Sam Houston State University, Conroe, TX 77304, USA |
| authorships[2].institutions[0].id | https://openalex.org/I191429286 |
| authorships[2].institutions[0].ror | https://ror.org/00yh3cz06 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I191429286 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Sam Houston State University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Hatem A. Elshabrawy |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Molecular and Cellular Biology, College of Osteopathic Medicine, Sam Houston State University, Conroe, TX 77304, USA |
| authorships[3].author.id | https://openalex.org/A5051855768 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-0628-5783 |
| authorships[3].author.display_name | Carlos da Silva Maia Bezerra Filho |
| authorships[3].countries | BR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I169045520 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, Brazil |
| authorships[3].institutions[0].id | https://openalex.org/I169045520 |
| authorships[3].institutions[0].ror | https://ror.org/00p9vpz11 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I169045520 |
| authorships[3].institutions[0].country_code | BR |
| authorships[3].institutions[0].display_name | Universidade Federal da Paraíba |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Carlos da Silva Maia Bezerra Filho |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, Brazil |
| authorships[4].author.id | https://openalex.org/A5021153759 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-7180-4896 |
| authorships[4].author.display_name | Damião Pergentino de Sousa |
| authorships[4].countries | BR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I169045520 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, Brazil |
| authorships[4].institutions[0].id | https://openalex.org/I169045520 |
| authorships[4].institutions[0].ror | https://ror.org/00p9vpz11 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I169045520 |
| authorships[4].institutions[0].country_code | BR |
| authorships[4].institutions[0].display_name | Universidade Federal da Paraíba |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Damião Pergentino de Sousa |
| authorships[4].is_corresponding | True |
| authorships[4].raw_affiliation_strings | Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, Brazil |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.mdpi.com/2218-273X/11/1/74/pdf?version=1610108687 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11882 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9993000030517578 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Plant biochemistry and biosynthesis |
| related_works | https://openalex.org/W4200329650, https://openalex.org/W3127156785, https://openalex.org/W4205754011, https://openalex.org/W3009669391, https://openalex.org/W4205215807, https://openalex.org/W3005417802, https://openalex.org/W4226296940, https://openalex.org/W3028835529, https://openalex.org/W3036314732, https://openalex.org/W3134376730 |
| cited_by_count | 56 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 7 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 6 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 8 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 20 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 15 |
| locations_count | 5 |
| best_oa_location.id | doi:10.3390/biom11010074 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210236520 |
| best_oa_location.source.issn | 2218-273X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2218-273X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Biomolecules |
| best_oa_location.source.host_organization | https://openalex.org/P4310310987 |
| best_oa_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.mdpi.com/2218-273X/11/1/74/pdf?version=1610108687 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Biomolecules |
| best_oa_location.landing_page_url | https://doi.org/10.3390/biom11010074 |
| primary_location.id | doi:10.3390/biom11010074 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210236520 |
| primary_location.source.issn | 2218-273X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2218-273X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Biomolecules |
| primary_location.source.host_organization | https://openalex.org/P4310310987 |
| primary_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.mdpi.com/2218-273X/11/1/74/pdf?version=1610108687 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Biomolecules |
| primary_location.landing_page_url | https://doi.org/10.3390/biom11010074 |
| publication_date | 2021-01-07 |
| publication_year | 2021 |
| referenced_works | https://openalex.org/W2057987200, https://openalex.org/W2899307702, https://openalex.org/W2306794997, https://openalex.org/W2491014331, https://openalex.org/W1905630967, https://openalex.org/W3001897055, https://openalex.org/W2132260239, https://openalex.org/W2999970538, https://openalex.org/W3015404155, https://openalex.org/W41083760, https://openalex.org/W1966238900, https://openalex.org/W2119111857, https://openalex.org/W3004348779, https://openalex.org/W3036932243, https://openalex.org/W3013430130, https://openalex.org/W2987822484, https://openalex.org/W6761039482, https://openalex.org/W2950748232, https://openalex.org/W2952998155, https://openalex.org/W6732988378, https://openalex.org/W2130479394, https://openalex.org/W3011701533, https://openalex.org/W3023006972, https://openalex.org/W2050456292, https://openalex.org/W2954476764, https://openalex.org/W2990527808, https://openalex.org/W3031226177, https://openalex.org/W3041986681, https://openalex.org/W293947926, https://openalex.org/W2118472743, https://openalex.org/W2183495699, https://openalex.org/W1985661966, https://openalex.org/W203309426, https://openalex.org/W2035509984, https://openalex.org/W2020896146, https://openalex.org/W1956339943, https://openalex.org/W2907067037, https://openalex.org/W2621867610, https://openalex.org/W2953306978, https://openalex.org/W2550942658, https://openalex.org/W2755619671, https://openalex.org/W2036009045, https://openalex.org/W2107220510, https://openalex.org/W1985652369, https://openalex.org/W2985346127, https://openalex.org/W2102380386, https://openalex.org/W2162867019, https://openalex.org/W2060366874, https://openalex.org/W1546884120, https://openalex.org/W745827319, https://openalex.org/W2101891159, https://openalex.org/W2006718722, https://openalex.org/W1977828927, https://openalex.org/W2105037592, https://openalex.org/W2166189758, https://openalex.org/W2029157859, https://openalex.org/W2093292832, https://openalex.org/W2155297294, https://openalex.org/W2970068576, https://openalex.org/W3034934060, https://openalex.org/W2132629607, https://openalex.org/W2074473216, https://openalex.org/W2159675211, https://openalex.org/W2056022472, https://openalex.org/W3024854102, https://openalex.org/W3034685222, https://openalex.org/W2010903641, https://openalex.org/W2934267501, https://openalex.org/W2581190460, https://openalex.org/W3102266411, https://openalex.org/W177323034 |
| referenced_works_count | 71 |
| abstract_inverted_index.a | 9, 29, 37, 70, 84 |
| abstract_inverted_index.In | 99 |
| abstract_inverted_index.as | 83, 90 |
| abstract_inverted_index.by | 8 |
| abstract_inverted_index.in | 28, 42 |
| abstract_inverted_index.is | 6, 69 |
| abstract_inverted_index.no | 52 |
| abstract_inverted_index.of | 20, 61, 66, 77, 86, 95, 108, 122, 130 |
| abstract_inverted_index.or | 89 |
| abstract_inverted_index.to | 24 |
| abstract_inverted_index.we | 103, 113 |
| abstract_inverted_index.Our | 124 |
| abstract_inverted_index.The | 0 |
| abstract_inverted_index.and | 22, 59, 112, 119 |
| abstract_inverted_index.are | 50, 73 |
| abstract_inverted_index.for | 32, 56, 92 |
| abstract_inverted_index.has | 36 |
| abstract_inverted_index.new | 87 |
| abstract_inverted_index.the | 12, 57, 64, 74, 93, 100, 105, 117, 128 |
| abstract_inverted_index.2019 | 3 |
| abstract_inverted_index.Mpro | 118 |
| abstract_inverted_index.date | 25 |
| abstract_inverted_index.have | 26 |
| abstract_inverted_index.high | 38 |
| abstract_inverted_index.that | 80 |
| abstract_inverted_index.with | 45 |
| abstract_inverted_index.Acute | 14 |
| abstract_inverted_index.PLpro | 120 |
| abstract_inverted_index.There | 49 |
| abstract_inverted_index.cases | 21 |
| abstract_inverted_index.class | 76 |
| abstract_inverted_index.could | 81 |
| abstract_inverted_index.drugs | 88 |
| abstract_inverted_index.human | 134 |
| abstract_inverted_index.novel | 10 |
| abstract_inverted_index.rate, | 40 |
| abstract_inverted_index.serve | 82 |
| abstract_inverted_index.these | 109, 131 |
| abstract_inverted_index.Severe | 13 |
| abstract_inverted_index.caused | 7 |
| abstract_inverted_index.deaths | 23 |
| abstract_inverted_index.global | 30 |
| abstract_inverted_index.source | 85 |
| abstract_inverted_index.study, | 102 |
| abstract_inverted_index.against | 116, 133 |
| abstract_inverted_index.agents. | 98 |
| abstract_inverted_index.chronic | 47 |
| abstract_inverted_index.discuss | 104 |
| abstract_inverted_index.disease | 2 |
| abstract_inverted_index.elderly | 43 |
| abstract_inverted_index.enzymes | 121 |
| abstract_inverted_index.largest | 75 |
| abstract_inverted_index.natural | 78, 110 |
| abstract_inverted_index.perform | 114 |
| abstract_inverted_index.present | 101 |
| abstract_inverted_index.results | 125 |
| abstract_inverted_index.suggest | 127 |
| abstract_inverted_index.COVID-19 | 35 |
| abstract_inverted_index.Millions | 19 |
| abstract_inverted_index.Syndrome | 16 |
| abstract_inverted_index.Terpenes | 72 |
| abstract_inverted_index.activity | 107 |
| abstract_inverted_index.pandemic | 5 |
| abstract_inverted_index.products | 79, 111 |
| abstract_inverted_index.resulted | 27 |
| abstract_inverted_index.strongly | 126 |
| abstract_inverted_index.systems. | 34 |
| abstract_inverted_index.COVID-19. | 62 |
| abstract_inverted_index.antiviral | 106 |
| abstract_inverted_index.challenge | 31 |
| abstract_inverted_index.compounds | 132 |
| abstract_inverted_index.currently | 51 |
| abstract_inverted_index.effective | 53, 67, 96 |
| abstract_inverted_index.including | 136 |
| abstract_inverted_index.mortality | 39 |
| abstract_inverted_index.potential | 129 |
| abstract_inverted_index.treatment | 60 |
| abstract_inverted_index.(COVID-19) | 4 |
| abstract_inverted_index.Therefore, | 63 |
| abstract_inverted_index.approaches | 55 |
| abstract_inverted_index.especially | 41 |
| abstract_inverted_index.healthcare | 33 |
| abstract_inverted_index.necessity. | 71 |
| abstract_inverted_index.prevention | 58 |
| abstract_inverted_index.prototypes | 91 |
| abstract_inverted_index.Respiratory | 15 |
| abstract_inverted_index.SARS-CoV-2. | 123, 137 |
| abstract_inverted_index.coronavirus | 1 |
| abstract_inverted_index.development | 94 |
| abstract_inverted_index.individuals | 44 |
| abstract_inverted_index.simulations | 115 |
| abstract_inverted_index.therapeutic | 54 |
| abstract_inverted_index.coronavirus; | 11 |
| abstract_inverted_index.pre-existing | 46 |
| abstract_inverted_index.therapeutics | 68 |
| abstract_inverted_index.(SARS-CoV-2). | 18 |
| abstract_inverted_index.Coronavirus-2 | 17 |
| abstract_inverted_index.comorbidities. | 48 |
| abstract_inverted_index.coronaviruses, | 135 |
| abstract_inverted_index.identification | 65 |
| abstract_inverted_index.pharmacotherapeutic | 97 |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 98 |
| corresponding_author_ids | https://openalex.org/A5021153759 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 5 |
| corresponding_institution_ids | https://openalex.org/I169045520 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8899999856948853 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.95322849 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |